Genetic investigations in cerebral palsy

Area of Science:

• Neuroscience
• Genetics
• Developmental Biology

Background:

• Cerebral palsy (CP) was historically linked to perinatal environmental stressors.
• Recent research reveals a substantial incidence (11-40%) of monogenic conditions in individuals diagnosed with CP.
• Genetic diagnoses enable personalized medicine approaches for CP management.

Purpose of the Study:

• To review the role of monogenic conditions in CP.
• To highlight the Wnt pathway and CTNNB1 gene variant in CP pathophysiology.
• To discuss the implications of genomic diagnosis in CP.

Main Methods:

• Review of studies on monogenic condition prevalence in CP clinics.
• Analysis of factors suggesting a genomic diagnosis.
• Examination of genotype-phenotype data needs for CP cohorts.

Main Results:

• Monogenic conditions are more prevalent in CP diagnoses than previously thought.
• Specific gene variants, such as CTNNB1 within the Wnt pathway, are implicated in CP.
• Genomic data interpretation requires comprehensive reference datasets.

Conclusions:

• Genomic insights are transforming the understanding and management of cerebral palsy.
• Accurate genetic diagnosis is vital for personalized treatment strategies.
• Societal and clinical implications of genomic CP management require careful consideration.